tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cresco Labs Expands Florida Footprint With New Sunnyside Tamarac Dispensary

Story Highlights
  • Cresco Labs opened its 31st Florida Sunnyside dispensary in Tamarac, expanding its U.S. medical cannabis footprint.
  • The new Sunnyside Tamarac store deepens Cresco’s brand presence and patient access in Florida’s key medical market.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cresco Labs Expands Florida Footprint With New Sunnyside Tamarac Dispensary

Claim 70% Off TipRanks Premium

Cresco Labs ( (TSE:CL) ) has issued an announcement.

Cresco Labs has opened a new Sunnyside dispensary in Tamarac, Florida, its 31st location in the state and 72nd nationwide, expanding its medical cannabis retail footprint in what it describes as the largest medical market in the U.S. The Sunnyside Tamarac store, located on North University Drive, offers a broad range of Cresco Labs’ branded cannabis products and accessories, supports both in-store and online ordering, and underscores the company’s strategy of deepening patient access, brand presence and customer education across Florida’s growing medical marijuana market.

The most recent analyst rating on (TSE:CL) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Cresco Labs stock, see the TSE:CL Stock Forecast page.

Spark’s Take on TSE:CL Stock

According to Spark, TipRanks’ AI Analyst, TSE:CL is a Neutral.

Cresco Labs’ overall stock score is primarily impacted by its financial performance challenges, including declining revenues and high leverage. Technical analysis shows moderate strength, while valuation remains weak due to negative profitability metrics. The earnings call provided some positive insights into strategic expansions and debt refinancing, but ongoing market challenges and operational adjustments weigh on the outlook.

To see Spark’s full report on TSE:CL stock, click here.

More about Cresco Labs

Cresco Labs is a U.S.-based cannabis company focused on cultivating, producing and distributing branded medical marijuana products and operating retail dispensaries under the Sunnyside banner. Positioned as a consumer packaged goods-style operator, it markets a portfolio of national brands including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, and emphasizes education-driven, approachable retail experiences alongside legislative and community engagement to help shape a regulated medical marijuana industry.

Average Trading Volume: 364,075

Technical Sentiment Signal: Hold

Current Market Cap: C$734.1M

For detailed information about CL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1